T22/0446 - Aseptically Manipulated or Terminally Sterile Medicinal Products
The supply of aseptically manipulated or terminally sterile products to NHS Trusts within the boundaries of the Peninsula Purchasing and Supply Alliance (PPSA). Products include dose-banded cytotoxic and non-cytotoxic batch and patient specific medicines in ready-to-use infusion bags, pre-filled syringes and elastomeric devices.
13/07/2023 12:00:00
33600000-6 Pharmaceutical products
33690000-3 Various medicinal products
33692100-8 Infusion solutions
33692500-2 Injectable solutions
33692510-5 Intravenous fluids
33693100-5 Toxins
Peninsula Purchasing & Supply Alliance
Royal Devon & Exeter Healthcare Trust (on behalf of PPSA)
| Notice | Date of dispatch |
|---|---|
| Live Opportunity (Contracts Finder) | 04/05/2023 15:38 |
| Contract notice (FTS) | |
Corrigendum (FTS)
|
|
|
Corrigendum (FTS)
|
|
| Contract award notice (FTS) |
Supply of Cyclophosphamide, Doxorubicin & Pembrolizumab.
Supply of Carboplatin, Epirubicin, Nivolumab & Paclitaxel.
Supply of Atezolizumab (Tecentriq®), Bortezomib Subcut, Docetaxel, Fluorouracil, Oxaliplatin & Vincristine.
Supply of Bleomycin, Cabazitaxel, Calcium folinate, Cisplatin, Cytarabine, Daunorubicin, Ganciclovir, Suxamethonium & Vinblastine.